Entecavir
Baraclude (entecavir) is a small molecule pharmaceutical. Entecavir was first approved as Baraclude on 2005-03-29. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b and hepatitis b.
Trade Name | Baraclude |
---|---|
Common Name | Entecavir |
Indication | chronic hepatitis b, hepatitis b |
Drug Class | Antivirals: carbocyclic nucleosides |